Institutional members access full text with Ovid®

Share this article on:

Characteristics of the env Genes of HIV Type 1 Quasispecies in Long-Term Nonprogressors With Broadly Neutralizing Antibodies

Braibant, Martine PhD*; Agut, Henri MD, PhD; Rouzioux, Christine PharmD, PhD; Costagliola, Dominique PhD§; Autran, Brigitte MD, PhD; Barin, Francis PharmD, PhD*

JAIDS Journal of Acquired Immune Deficiency Syndromes: March 1st, 2008 - Volume 47 - Issue 3 - p 274-284
doi: 10.1097/QAI.0b013e318162cac2
Basic Science

Primary isolates of different subtypes of HIV-1 can be neutralized in vitro by the broadly neutralizing antibodies (NAbs) found in the sera of a small number of HIV-1-infected patients. This broad response is most frequent in long-term nonprogressors (LTNPs). We investigated whether the presence of NAbs in the sera of some LTNPs was associated with particular properties of the envelope glycoproteins of the variants found in these patients. Toward that aim, 147 env gene fragments (encoding almost the entire gp120) amplified from the proviral DNA of 5 LTNPs who developed broadly NAbs (NAb+) and of 4 LTNPs who did not develop such broadly NAbs (NAb-) were cloned, sequenced, and compared. We found that the development of broadly NAbs was associated with high viral loads, greater diversity in the gp120 of the viruses infecting these patients, and longer V1 sequences and additional N-gly sites in V1. In addition, a higher proportion of defective clones was found among the env genes of NAb- patients (25% to 93%)-particularly those with lower viral loads and low levels of env diversity-than among those of NAb+ patients (7% to 19%).

From the *Université François-Rabelais, Tours, France; †Laboratoire de Virologie, Hôpital Pitié-Salpêtrière, Paris, France; ‡Laboratoire de Virologie, Hôpital Necker-Enfants Malades, Paris, France; §Université Pierre et Marie Curie, Paris, France; and the ∥Laboratoire d'Immunologie Cellulaire et Tissulaire, Hôpital Pitié-Salpêtrière, Paris, France.

Received for publication July 13, 2007; accepted November 20, 2007.

Supported by a grant from the Agence Nationale de Recherche sur le SIDA (ANRS), Paris. Martine Braibant was supported by postdoctoral fellowships from ANRS and Sidaction, Paris.

Data presented at the Conference on Retroviruses and Opportunistic Infections, Los Angeles, CA, February 25-28, 2007.

Correspondence to: Francis Barin, PharmD, PhD, Laboratoire de Virologie, CHU Bretonneau, 37044 Tours Cedex, France (e-mail:

© 2008 Lippincott Williams & Wilkins, Inc.